Interleukin-6 and its receptor in chronic lymphatic leukaemia
Author Information
Author(s): I. Drucker, A. Klajman, M. Revel, Y. Manor, S. Ben-Efraim, D. Novick
Primary Institution: Meir Hospital and The Weizmann Institute of Science
Hypothesis
The study aimed to determine the levels of IL-6 and sIL-6R in cultures of B-CLL lymphocytes and normal B lymphocytes.
Conclusion
B-CLL lymphocytes produce IL-6 and sIL-6R, with PMA stimulation decreasing IL-6 levels and increasing sIL-6R levels.
Supporting Evidence
- B-CLL lymphocytes produced IL-6 and sIL-6R in vitro without specific stimulation.
- PMA stimulation decreased IL-6 levels in 12 out of 15 cases.
- Serum levels of sIL-6R correlated with the number of B-CLL lymphocytes.
Takeaway
The study found that a type of immune cell in leukemia makes a substance called IL-6, which helps it grow, and another substance that can be measured in the blood.
Methodology
The study involved culturing B-CLL lymphocytes and normal B lymphocytes, measuring IL-6 and sIL-6R levels in supernatants and sera.
Limitations
The small number of B-CLL patients in advanced stages limited correlation analysis.
Participant Demographics
B-CLL patients and normal volunteers, with varying stages of B-CLL according to Rai classification.
Statistical Information
P-Value
p 0.0044; p 0.0003
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website